NCT07021989 2026-03-17ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin LymphomaUniversity of California, San FranciscoPhase 2 Not yet recruiting38 enrolled
NCT06594939 2026-02-04Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell LymphomaMedical College of WisconsinPhase 2 Not yet recruiting31 enrolled